Dr. John Lambert, a world renowned expert and pioneer in the field of Antibody Drug Conjugates is joining the Scientific Advisory Board of Singzyme. Dr Lambert bring over 40 years of experience in the field of Bioconjugates.
The team led by Prof. Liu Chuan Fa from NTU and Singzyme Co-founder published a groundbreaking work in the Journal of American Chemical Society describing how a cascade reaction scheme makes an irreversible transpeptidative protein ligation possible.
Join the Singzyme team in London from the 13th to the 16th of February 2023 for the World ADC Europe conference!
Singzyme will present its technology during the Discovery stream session.
Join Singzyme for the Next-generation Bioconjugates Summit that will be held in Boston from the 21st to the 23rd of February 2023.
1 November 2022
6-8 September 2022
15 July 2022: USA, Europe, and China Patent application granted. Patent application held by Nanyang Technological University and licensed exclusively to Singzyme provides protection to the Singzyme technology platform.
11-12 May 2022:
Singzyme is invited to present its technology to the Lonza bioconjugates Summit in Visp, Switzerland